RxDoctor Payments Data

Rachel Diteresi, MD

Obstetrics & Gynecology · Kansas City, KSNPI 1477878494

Payments from drug & device makers

What this record shows

Pfizer accounts for 91.6% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $1,533 and has fallen 91.9% since, to $125 in 2023.

$1,673in general payments, 2019–2025

Across 6 payments — averaging $278.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$2K
  • Astellas Pharma US Inc$125
  • Bayer$15
$253,763in research payments, 2019–2025

Across 54 payments — averaging $4699.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$254K

What the payments were for

  • Travel & lodging$87852%
  • Food & beverage$79548%

General payments by program year

19
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer4$1,533
Astellas Pharma US Inc1$125
Bayer1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,673 in reported general payments places this provider in the 60th percentile of 302 obstetrics & gynecology providers in Kansas.

See all obstetrics & gynecology providers in Kansas

Medicare billing

Part B allowed, 2024
$4,789
Medicare patients
21
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →